GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 14/12/2010
PIL Adartrel 0.25, 0.5, and 2.0 mg film-coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/12/2010 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 24/08/2010 and displayed until 14/12/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to manufacturer contact details
Updated on 06/04/2009 and displayed until 24/08/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 13/02/2009 and displayed until 06/04/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 24/08/2007 and displayed until 13/02/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 18/07/2006 and displayed until 24/08/2007
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 18/05/2006 and displayed until 18/07/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   ropinirole hydrochloride